Advisory Board and Editors Biochemistry

Journal Factsheet
A one-page PDF to help when considering journal options with co-authors
Download Factsheet
I told my colleagues that PeerJ is a journal where they need to publish if they want their paper to be published quickly and with the strict peer review expected from a good journal.
Sohath Vanegas,
PeerJ Author
View author feedback

Sapna Langyan

Sapna Langyan is a scientist at ICAR-National Bureau of Plant Genetic Resources, New Delhi, India. She holds an experience of more than 11 years in agricultural research. She aims to contribute towards food and nutritional security of the world and alleviating malnutrition through research support. She has more than 30 research papers, book chapters, conference proceedings and many others in reputed national and international journals and also holds editorship of many reputed journals including Frontiers. She has also edited one book on ‘Maize: Nutrition dynamics and novel uses’, published by Springer https://www.springer.com/gp/book/9788132216223. She has been awarded many prestigious awards, fellowship and grants throughout her research career by premier science academies and by the Govt. of India.

Bill P Leggat

I was awarded my PhD from James Cook University in 2001 where my research project focussed on photosynthesis and bleaching in the symbiotic giant clam Tridacna gigas. I then moved to the University of Queensland where I was a Postdoctoral Research Fellow in the Centre for Marine Studies in the laboratory of Prof Ove Hoegh-Guldberg. In 2007 I returned to James Cook Univeristy as a Lecturer in the discpline of Biochemistry, I am now a Associate Professor and head of the Symbiosis Genomics Research Group and a Chief Investigator in the ARC Centre of Excellence for Coral Reef Studies. The overarching aim of my research is to link transcriptomic and metabolomic changes to whole organism responses and acclimation. My research utilises genomic and metabolomic techniques to determine how the coral holobiont responds to anthropogenic changes, including increasing temperatures, ocean acidification and eutrophication.

Jack C. Leo

I study bacterial pathogenesis, focusing on autotransporters of Gram-negative bacteria. These proteins are self-contained secretion systems and surface molecules that mediate a number of virulence functions. I aim to understand three aspects of autotransporter-mediated pathogenesis: 1) the mechanisms of virulence functions, 2) the biogenesis of autotransporters and 3) regulation of gene expression. All three are potential sites for intervention to prevent host colonisation and infection.

Liudmila P Leppik

Assistant Director, Frankfurt Initiative for Regenerative Medicine, J.W. Goethe-Universität, Friedrichsheim Orthopedic University Hospital.

Dr. Leppik’s research background is in the fields of molecular biology and virology in Russia and Germany. Specifically her research focused on human genome activity and regulation of gene expression during tumor genesis and development and differentiation. Her current research at FIRM focuses on tissue development and regeneration.

Florian Lesage

Florian Lesage is senior research director at INSERM (French National Health Institute). He is a molecular biologist with extensive experience in ion channel cloning, expression and characterization, in particular in the neurosensory systems. He has authored 15 international patents and >120 publications that have received more than 15,000 citations (http://scholar.google.fr/citations?user=4RXbfuMAAAAJ&hl=fr&oi=ao).
Florian Lesage is the director of the Laboratoire d'Excellence "Ion Channel Science and Therapeutics" (LabEx ICST, www.labex-icst.fr/en).

David Levine

David Levine, PT, PhD, DPT, Diplomate ABPTS, CCRP, Cert. DN
Dr. Levine is a Professor and the Walter M. Cline Chair of Excellence in Physical Therapy at the University of Tennessee at Chattanooga. He is an adjunct professor at the University Of Tennessee College Of Veterinary Medicine and North Carolina State University College of Veterinary Medicine. In addition, he is board certified as a specialist in orthopedics by the American Board of Physical Therapy Specialties and is also certified in dry needling. Dr. Levine has been working and conducting research in many areas with an emphasis in veterinary physical rehabilitation and is co-director of the University of Tennessee certificate program in canine rehabilitation. He is a co-editor of multiple books including “Canine Rehabilitation and Physical Therapy”, “Essential Facts of Physiotherapy in Dogs and Cats”, and Gait Analysis: An Introduction. He continues to practice in canine rehabilitation and human physical therapy in addition to his University position. He has presented at over 100 conferences, and has lectured in more than a dozen countries. Dr. Levine has published in numerous peer-reviewed journals with over 75 publications. His latest research focuses on bacterial contamination in medical equipment, animal assisted therapy, and laser to improve muscle endurance.

Raphaël Lévy

PhD, physics, Strasbourg, France, 2002, polymer adsorption with the Atomic Force Microscope

Post-doctoral fellowship, Liverpool, UK, Design of peptides as capping agents for gold nanoparticles

BBSRC David Phillips Fellow, Liverpool, 2006-11, Nanoparticle-based imaging in living cells; biomimetic nanoparticles
2011- Lecturer, then Senior Lecturer, University of Liverpool

Our research focuses on nanoparticles, their structure, and applications, in particular for biological imaging both at the single molecule level and for cell tracking in animal models.

Zhiming Li

Dr. Zhiming Li is an early career researcher at Columbia University. His primary research focus is on epigenetic inheritance and cancer epigenetics, and his long-term goals are to understand the fundamental mechanisms of epigenetic inheritance and how such mechanisms and epigenetic alterations are involved in tumorigenesis, which eventually would allow him to identify druggable targets for cancer intervention.

Xing Li

Dr. Xing Li is an Assistant Professor and Associate Consultant in the Division of Biomedical Statistics and Informatics, Department of Health Science Research at Mayo Clinic - voted the best hospital by U.S. News & World Report. Dr. Li completed his PhD in Bioinformatics from The University of Michigan at Ann Arbor, Michigan, USA. Dr. Li also holds a Masters Degree in Biochemistry and Molecular Biology and Bachelors Degree in Microbiology. Dr. Li’s research interests focus on machine learning, bioinformatics, and statistical data mining in large scale data in biomedical research, such as next generation sequencing data (whole genome sequencing, RNA-seq, microarray data), in the file. He has published more than 20 peer-reviewed papers in reputable journals and book chapters in the fields of Bioinformatics and Biostatistics, cancer research, cardiovascular disease, embryonic stem cell (ESC) and induced pluripotent stem cell (iPSC) research, and human genomics, genetics and development, and Microbiology. Dr. Li’s publications have been highlighted as Journal Cover Stories, Journal Featured Articles, Highlights Section Papers, Must Read by Faculty 1000, and ESC & iPSC News, etc. Dr. Li has been developing data analysis tools, such as RCircle and PCA3d, etc. Dr. Li is also a member of American Association for Cancer Research (AACR), International Society for Computational Biology (ISCB), American Statistics Association (ASA) and American Heart Association (AHA).

Ning Li

Prof. Li received his Medical Doctorate in 2005 as an outstanding graduate of the Chinese Union Medical University (CUMU). In the same year, he worked in the Department of Thoracic Surgery at the Cancer Hospital of the Chinese Academy of Medical Sciences, where he served as an attending physician, deputy chief physician, and was appointed Chief Physician in 2019. He has a solid theoretical foundation and excellent research ability, and has accumulated rich clinical experience during my work. In 2017, he took over as the Director of the Office of Drug Clinical Trial Research Center, and his outstanding achievements in the management of clinical trial institutions and clinical and translational research, and is currently served as the chief expert of China GCP platform and Leading PI of international multicenter clinical trials of anti-cancer drug discovery. He is committed to new anti-tumor drug research, real-world research, full chain translation research of clinical trials, precision treatment of rare tumors and tumor big data research. His H-Index is 44 based on Web of Science. As a sub-project leader of the National 973 Major Project, the National Key R&D Program for Precision Medicine, the National Natural Science Foundation of China, the GCP platform leader, and the leader of the 13th and 14th Five-Year Innovation Project, he has undertaken many research projects.

Feng Liu

Feng Liu received his Ph.D. degree from the School of Life Science and Technology, University of Electronic Science and Technology of China and went on to work in the Department of Radiology and Tianjin Key Laboratory of Functional Imaging, Tianjin Medical University General Hospital, China. Now he is an associate professor and his current research interests include Brain and Cognition, Magnetic Resonance Imaging, Imaging Genetic and Multivariate Pattern Analysis.

Current research focuses on investigating the impact of the environmental factors (e.g., green space, PM 2.5, etc) on human brain measured by magnetic resonance imaging.

Homepage: https://fengliu001.github.io/

L.Maria Lois

Current position: Group leader at CRAG
Research: Role of SUMO in Plant Development
Career:
2008- :Assistant Professor, Spanish Research Council CSIC.
2004 2008: RyC Research Associate, University of Barcelona, Barcelona, Spain.
2003- 2004: Postdoctoral associate, MSKCC, N.Y., USA.
2002- 2003: Postdoctoral associate, WMC of Cornell University, N.Y., USA.
1999- 2002: Postdoctoral fellow, The Rockefeller University, New York, N.Y., USA.
1999: Ph.D. in Biochemistry, University of Barcelona.